221 related articles for article (PubMed ID: 6638954)
1. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
Rice GP; Casali P; Merigan TC; Oldstone MB
Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
[TBL] [Abstract][Full Text] [Related]
2. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
[TBL] [Abstract][Full Text] [Related]
3. [Change in the activity of natural killer cells in normal subjects and in virus diseases on exposure to interferon in vitro].
Petrov RV; Saidov MZ; Koval'chuk LV; Sorokin AM; Kaganov BS
Biull Eksp Biol Med; 1984 Apr; 97(4):438-40. PubMed ID: 6722306
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
Edwards BS; Hawkins MJ; Borden EC
Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
[TBL] [Abstract][Full Text] [Related]
6. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
[TBL] [Abstract][Full Text] [Related]
7. Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines.
Lederman MM; Ratnoff OD; Schacter B; Shoger T
J Lab Clin Med; 1985 Aug; 106(2):197-204. PubMed ID: 2410523
[TBL] [Abstract][Full Text] [Related]
8. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
Koren HS; Brandt CP; Tso CY; Laszlo J
J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human natural killer cell cytotoxicity by recombinant leukocyte interferon clone A.
Lotzová E; Savary CA; Gutterman JU; Quesada JR; Hersh EM
J Biol Response Mod; 1983; 2(5):482-96. PubMed ID: 6644351
[TBL] [Abstract][Full Text] [Related]
11. Interferon enhanced natural killer function in Hodgkin's disease.
Levy S; Reins F; Aleksijevic A; Giron C; Oberling F; Mayer S; Lang JM
Nouv Rev Fr Hematol (1978); 1986; 28(5):323-5. PubMed ID: 3808943
[TBL] [Abstract][Full Text] [Related]
12. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
[TBL] [Abstract][Full Text] [Related]
13. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
Auer IO; Ziemer E; Sommer H
Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390
[TBL] [Abstract][Full Text] [Related]
14. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
15. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
Gigli G; Caielli S; Cutuli D; Falcone M
Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
[TBL] [Abstract][Full Text] [Related]
17. Effects of theophylline on human natural killer cells.
Marshall ME; Phillips B; Riley LK; Rhoades JR; Brown S; Jennings CD
Immunopharmacol Immunotoxicol; 1989; 11(1):1-16. PubMed ID: 2760413
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line.
Zhou J; Olsen S; Moldovan J; Fu X; Sarkar FH; Moudgil VK; Callewaert DM
Cell Immunol; 1997 Jun; 178(2):108-16. PubMed ID: 9225001
[TBL] [Abstract][Full Text] [Related]
19. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
Miles EA; Banerjee T; Wells SJ; Calder PC
Nutrition; 2006 May; 22(5):512-9. PubMed ID: 16600816
[TBL] [Abstract][Full Text] [Related]
20. Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy.
Spina CA; Fahey JL; Durkos-Smith D; Dorey F; Sarna G
J Biol Response Mod; 1983; 2(5):458-69. PubMed ID: 6644350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
